These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 10969806

  • 21. Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line.
    Chang KL, Cheng HL, Huang LW, Hsieh BS, Hu YC, Chih TT, Shyu HW, Su SJ.
    Cancer Lett; 2009 Apr 08; 276(1):14-20. PubMed ID: 19091461
    [Abstract] [Full Text] [Related]

  • 22. Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.
    Kyprianou N, Jacobs SC.
    Curr Urol Rep; 2000 Aug 08; 1(2):89-96. PubMed ID: 12084321
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A.
    Cancer Res; 2001 Jul 15; 61(14):5432-40. PubMed ID: 11454688
    [Abstract] [Full Text] [Related]

  • 29. Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha1-adrenergic receptor antagonist.
    Boesch ST, Corvin S, Zhang J, Rogatsch H, Bartsch G, Klocker H.
    Prostate; 1999 Jun 01; 39(4):226-33. PubMed ID: 10344211
    [Abstract] [Full Text] [Related]

  • 30. Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction.
    Partin JV, Anglin IE, Kyprianou N.
    Br J Cancer; 2003 May 19; 88(10):1615-21. PubMed ID: 12771931
    [Abstract] [Full Text] [Related]

  • 31. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
    Srivastava SK, Xiao D, Lew KL, Hershberger P, Kokkinakis DM, Johnson CS, Trump DL, Singh SV.
    Carcinogenesis; 2003 Oct 19; 24(10):1665-70. PubMed ID: 12896904
    [Abstract] [Full Text] [Related]

  • 32. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 19; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 33. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L, Zhu Z, Joshi B, Porter AT, Tang DG.
    Anticancer Res; 1999 Aug 19; 19(1A):51-60. PubMed ID: 10226524
    [Abstract] [Full Text] [Related]

  • 34. Doxazosin-induced clusterin expression and apoptosis in prostate cancer cells.
    Youm YH, Yang H, Yoon YD, Kim DY, Lee C, Yoo TK.
    Urol Oncol; 2007 Aug 19; 25(6):483-8. PubMed ID: 18047956
    [Abstract] [Full Text] [Related]

  • 35. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
    Kojima Y, Sasaki S, Oda N, Koshimizu TA, Hayashi Y, Kiniwa M, Tsujimoto G, Kohri K.
    Prostate; 2009 Oct 01; 69(14):1521-8. PubMed ID: 19544328
    [Abstract] [Full Text] [Related]

  • 36. [Effect of nitric oxide donor and alpha1-receptor antagonist on proliferation/apoptosis of hyperplastic prostatic stromal cells in vitro].
    Deng CH, Chen HR, Qiu SP, Liu JZ, Zheng KL, Mei H.
    Zhonghua Wai Ke Za Zhi; 2004 Feb 22; 42(4):201-4. PubMed ID: 15062034
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.
    Thomas D, Wimmer AB, Wu K, Hammerling BC, Ficker EK, Kuryshev YA, Kiehn J, Katus HA, Schoels W, Karle CA.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 May 22; 369(5):462-72. PubMed ID: 15098086
    [Abstract] [Full Text] [Related]

  • 38. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
    Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM.
    Cancer Res; 2000 Sep 15; 60(18):5165-70. PubMed ID: 11016644
    [Abstract] [Full Text] [Related]

  • 39. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM, Ouafik L.
    Cancer Res; 2001 Feb 01; 61(3):1196-206. PubMed ID: 11221851
    [Abstract] [Full Text] [Related]

  • 40. Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation.
    Shaw YJ, Yang YT, Garrison JB, Kyprianou N, Chen CS.
    J Med Chem; 2004 Aug 26; 47(18):4453-62. PubMed ID: 15317457
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.